Literature DB >> 12823282

Humoral response against Cryptococcus neoformans mannoprotein antigens in HIV-infected patients.

L Pitzurra1, S Perito, F Baldelli, F Bistoni, A Vecchiarelli.   

Abstract

Twenty-four sera from healthy donors, 18 from HIV-positive patients (< 200 CD4+/mm3) and 18 sera collected before and during cryptococcosis from HIV-positive patients were analysed for the presence of humoral response to C. neoformans mannoproteins. Our results show that samples from healthy subjects and from HIV-positive patients had one of three antibody response profiles: (i) presence of reactive antibodies against both 105 and 80 kilodalton mannoproteins; (ii) presence of reactive antibodies against one of the two mannoproteins; or (iii) absence of reactive antibodies. Importantly the percentage of unreactive sera increased 6-fold in HIV-positive patients and more than 10-fold in patients with cryptococcosis. In addition, in the latter patients no variation of humoral response before and during cryptococcosis was observed. These results suggest that HIV-positive patients show a marked difficulty in mounting or maintaining antibody response to mannoprotein and this could contribute to predisposition to cryptococcosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12823282      PMCID: PMC1808755          DOI: 10.1046/j.1365-2249.2003.02181.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Dysregulation in IL-12 secretion by neutrophils from HIV-infected patients.

Authors:  A Vecchiarelli; C Monari; B Palazzetti; F Bistoni; A Casadevall
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

Review 2.  Induced humoral immunity and vaccination against major human fungal pathogens.

Authors:  Arturo Casadevall; Marta Feldmesser; Liise-anne Pirofski
Journal:  Curr Opin Microbiol       Date:  2002-08       Impact factor: 7.934

Review 3.  Immunoregulation by capsular components of Cryptococcus neoformans.

Authors:  A Vecchiarelli
Journal:  Med Mycol       Date:  2000-12       Impact factor: 4.076

4.  The morphology of Cryptococcus neoformans in human cryptococcosis. A light-,phase-contrast and electron-microscopic study.

Authors:  H Stoetzner; C Kemmer
Journal:  Mycopathol Mycol Appl       Date:  1971-12-06

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Toll-like receptor 4 mediates intracellular signaling without TNF-alpha release in response to Cryptococcus neoformans polysaccharide capsule.

Authors:  S Shoham; C Huang; J M Chen; D T Golenbock; S M Levitz
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

7.  Sustained plasma TNF-alpha and HIV-1 load despite resolution of other parameters of immune activation during treatment of tuberculosis in Africans.

Authors:  S D Lawn; R J Shattock; J W Acheampong; R B Lal; T M Folks; G E Griffin; S T Butera
Journal:  AIDS       Date:  1999-11-12       Impact factor: 4.177

8.  Do kinetics of the humoral response to Cryptococcus neoformans proteins during murine cryptococcosis reflect outcome?

Authors:  S Neuville; O Lortholary; F Dromer
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

9.  Analysis of antibody response to Cryptococcus neoformans in five patients with AIDS and cryptococcosis by immunoblotting.

Authors:  L Lamura; R C Matthews; F Barchiesi; M Donahoe; J P Burnie; G Scalise
Journal:  J Infect       Date:  2000-01       Impact factor: 6.072

10.  Purification and characterization of a second immunoreactive mannoprotein from Cryptococcus neoformans that stimulates T-Cell responses.

Authors:  Chao Huang; Shu-Hua Nong; Michael K Mansour; Charles A Specht; Stuart M Levitz
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

View more
  7 in total

1.  Recreational drug use and risk of Kaposi's sarcoma in HIV- and HHV-8-coinfected homosexual men.

Authors:  Chun Chao; Lisa P Jacobson; Frank J Jenkins; Donald Tashkin; Otoniel Martínez-Maza; Michael D Roth; Leslie Ng; Joseph B Margolick; Joan S Chmiel; Zuo-Feng Zhang; Roger Detels
Journal:  AIDS Res Hum Retroviruses       Date:  2009-02       Impact factor: 2.205

2.  Antibody responses to Cryptococcus neoformans in Indian patients with cryptococcosis.

Authors:  Dolan Champa Saha; Immaculata Xess; Wang Yong Zeng; David L Goldman
Journal:  Med Mycol       Date:  2008-03-10       Impact factor: 4.076

3.  Immunoglobulin VH gene diversity and somatic hypermutation during SIV infection of rhesus macaques.

Authors:  Kejun Guo; Kalani Halemano; Kimberly Schmitt; Miki Katuwal; Yaqiong Wang; Michael S Harper; Karl J Heilman; Takeo Kuwata; Edward B Stephens; Mario L Santiago
Journal:  Immunogenetics       Date:  2015-05-21       Impact factor: 2.846

4.  Glucuronoxylomannan, galactoxylomannan, and mannoprotein occupy spatially separate and discrete regions in the capsule of Cryptococcus neoformans.

Authors:  Magdia De Jesus; André Moraes Nicola; Siu-Kei Chow; Ian R Lee; Shuhua Nong; Charles A Specht; Stuart M Levitz; Arturo Casadevall
Journal:  Virulence       Date:  2010-11-01       Impact factor: 5.882

5.  Characterization of two novel cryptococcal mannoproteins recognized by immune sera.

Authors:  Carmelo Biondo; Luciano Messina; Mauro Bombaci; Giuseppe Mancuso; Angelina Midiri; Concetta Beninati; Valentina Cusumano; Elisabetta Gerace; Salvatore Papasergi; Giuseppe Teti
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

6.  Serologic evidence for reactivation of cryptococcosis in solid-organ transplant recipients.

Authors:  D C Saha; D L Goldman; X Shao; A Casadevall; S Husain; A P Limaye; M Lyon; J Somani; K Pursell; T L Pruett; N Singh
Journal:  Clin Vaccine Immunol       Date:  2007-10-24

7.  Identification of Disease-Associated Cryptococcal Proteins Reactive With Serum IgG From Cryptococcal Meningitis Patients.

Authors:  A Elisabeth Gressler; Daniela Volke; Carolina Firacative; Christiane L Schnabel; Uwe Müller; Andor Krizsan; Bianca Schulze-Richter; Matthias Brock; Frank Brombacher; Patricia Escandón; Ralf Hoffmann; Gottfried Alber
Journal:  Front Immunol       Date:  2021-07-23       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.